A Study of Gastric Delay in Migraine Patients (3207-003)

A Randomized, Double-Blind, Placebo Controlled, 2-Period, Fixed-Sequence Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Orally Administered MK3207 in Patients During and Between Their Acute Migraine Attacks

A study to assess safety and PK of an investigational drug in migraine patients during and between migraine attacks.

Inclusion Criteria:

• Non-smoking male or female between 18 to 45 years of age
• Patient typically has between 2 and 10 migraine attacks per month, rated as moderate or severe

Exclusion Criteria:

• Patient has any other medical conditions other than migraine